Pharmaceutical composition comprising sulbactam and avibactam, and application thereof
Inventors
Ma, Zhenkun • Xu, Yue • Liu, Yu • WANG, Huan • He, Shijie • Zhang, Yan • XU, Xiangyi
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present application relates to a pharmaceutical composition comprising sulbactam or a pharmaceutically acceptable salt thereof, avibactam or a pharmaceutically acceptable salt thereof, and optionally a pharmaceutically acceptable carrier, wherein unit dose ratio of said sulbactam or the pharmaceutically acceptable salt thereof and said avibactam or the pharmaceutically acceptable salt thereof is about 8:1 to about 4:1, unit dose of said sulbactam or the pharmaceutically acceptable salt thereof is about 1 g-4 g, and unit dose of said avibactam or the pharmaceutically acceptable salt thereof is about 0.125 g-1 g. The present application also relates to methods of treating bacterial infections using said pharmaceutical composition.
Core Innovation
The invention describes pharmaceutical compositions comprising sulbactam or a pharmaceutically acceptable salt thereof and avibactam or a pharmaceutically acceptable salt thereof, with a specified unit-dose ratio and dose ranges. It also describes compositions with a specified pH range and injectable formulations. The disclosed treatment method administers the agents at a specified ratio and daily dosage ranges to prevent, treat, or alleviate bacterial infections.
The partial content identifies drug-resistant bacterial infections, particularly infections involving Acinetobacter baumannii, as relevant to the disclosed treatment. It reports lower minimum inhibitory concentrations for certain combinations and reduced lung bacterial burden in a mouse pneumonia model. The background section is not included in the supplied content, so the problem being solved is not explicitly described in patent.
Claims Coverage
The two independent claims cover a pharmaceutical composition and a method for preventing, treating, or alleviating bacterial infections, setting forth two inventive features.
Sulbactam and avibactam pharmaceutical composition
A pharmaceutical composition comprising sulbactam or a pharmaceutically acceptable salt thereof and avibactam or a pharmaceutically acceptable salt thereof, optionally with a pharmaceutically acceptable carrier, at a specified unit-dose ratio and within specified unit-dose ranges.
Administration of sulbactam and avibactam for bacterial infections
A method for preventing, treating, or alleviating bacterial infections by administering sulbactam or a pharmaceutically acceptable salt thereof and avibactam or a pharmaceutically acceptable salt thereof at a specified administration ratio and within specified daily dosage ranges.
The independent claims cover the composition of the two agents and their administration for bacterial infections, with specified ratio and dosage constraints.
Stated Advantages
The disclosed combinations show lower minimum inhibitory concentrations than monotherapy or the comparison combination described in the partial content.
The mouse pneumonia results show reduced lung bacterial burden across the tested doses.
The summary reports plasma drug levels above the minimum inhibitory concentration for more than half of the dosing interval at the low dose.
Documented Applications
Prevention, treatment, or alleviation of bacterial infections, particularly drug-resistant infections involving Acinetobacter baumannii.
Injectable formulations of the sulbactam and avibactam composition.
A kit or administration device comprising the pharmaceutical composition.
Interested in licensing this patent?